PAVmed (PAVM) Operating Expenses (2015 - 2026)

PAVmed has reported Operating Expenses for 12 years, with the latest figure at $7.1 million in Q2 2026.

• On a quarterly basis, Operating Expenses rose 49.44% year-over-year to $7.1 million in Q2 2026; TTM through Jun 2026 was $23.5 million, a 21.82% decrease from a year earlier, with the FY2025 full-year figure at $21.9 million, down 53.93% from the prior year.
• Operating Expenses was $7.1 million for Q2 2026 at PAVmed, up from $6.9 million in the prior quarter.
• The five-year high for Operating Expenses was $24.7 million in Q4 2022, with the low at $4.7 million in Q2 2025.
• Average Operating Expenses over 5 years is $14.2 million, with a median of $15.7 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2024: Operating Expenses surged 145.44% in 2022, then slumped 70.19% in 2024.
• Over 5 years, Operating Expenses stood at $24.7 million in 2022, then declined by 29.46% to $17.4 million in 2023, then plunged by 70.19% to $5.2 million in 2024, then surged by 31.9% to $6.9 million in 2025, then climbed by 2.92% to $7.1 million in 2026.
• The last three Operating Expenses figures came in at $7.1 million (Q2 2026), $6.9 million (Q4 2025), and $4.8 million (Q3 2025), per Business Quant data.